• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi, Feb. 22

Ranbaxy Laboratories' Romanian subsidiary Terapia has received manufacturing and import authorisation from Romanian Regulatory Agency, and now has permission to batch test and release products manufactured outside European Union.

In an official statement released by the company, Ranbaxy said that it intends to transform Terapia-Ranbaxy into a strategic regional hub for the company's operations in Europe. The Indian pharma major acquired Terapia in March last year for about $324 million. Ranbaxy has also expressed its interest in acquiring Merck KGaA's generic business, and is expected to make a bid for it very soon.

More Stories on : Announcements | Pharmaceuticals | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Evolvence India to invest $10 m in Bangalore co

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line